A treatment regimen composed of repeated intravenous injections of MSCs or MSC_IGF-1 (Figure 1(a)) was associated with increased mortality (40% for the MSC group and 30% for the MSC_IGF-1 group) in mice chronically infected with T. cruzi, due to pulmonary embolism. Here, IGF1 is linked to pulmonary embolism.